Lung Cancer News and Research

Latest Lung Cancer News and Research

Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients

Cancer is the world's second deadliest disease which contributes towards the fatality of over 10 million people per year.

3 Apr 2021

Study: More than 60% of adult e-cigarette users in the U.S want to quit

More than 60% of U.S. adults who vape are interested in quitting, according to a study published today in JAMA Network Open by MUSC Hollings Cancer Center researchers.

3 Apr 2021

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

The College of American Pathologists (CAP), in collaboration with five other societies, developed a draft evidence-based clinical practice guideline that aims to optimize PD-L1 testing for patients with non-small cell lung cancer (NSCLC) who are being considered for immunooncology therapy.

1 Apr 2021

Researchers receive $4.5 million grant to support lung cancer screenings and research

Two researchers from the University of Minnesota Medical School, who also practice at the Minneapolis VA Health Care System, join the Omaha VA Medical Center to lead the Upper Midwest VA Lung Cancer Screening and Research Network as part of a nationwide VA-funded Lung Precision Oncology Program (LPOP).

1 Apr 2021

Objectives, challenges and opportunities of new IASLC Molecular Database Project

A new Molecular Database Project initiated by the International Association for the Study of Lung will accelerate the understanding of lung cancer biology, clinical care and care delivery on a global scale and will improve the prognosis and optimal treatment of lung cancer across time and space, according to an editorial in the Journal of Thoracic Oncology, an official journal of the IASLC.

31 Mar 2021

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.

31 Mar 2021

UVA expert helps develop new lung cancer screening guidelines for high-risk patients

Through his role on the U.S. Preventive Services Task Force, UVA Health's Li Li, MD, PhD, MPH, has helped develop new lung cancer screening guidelines that expand screenings to more high-risk patients.

30 Mar 2021

UCLA researchers receive NIH grants to identify new ways to treat pancreatic cancer

A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.

25 Mar 2021

Smoking cessation therapy for hospitalized patients may help avoid many premature deaths

Smoking cigarettes causes 480,000 premature deaths each year in the United States, due mainly to a two-fold risk of cardiovascular disease and a 20-fold risk of lung cancer. Although smoking rates have declined dramatically, there are currently 35 million smokers in the U.S.

25 Mar 2021

NCCN Annual Conference discusses new ways to improve cancer care

New recommendations to advance racial equity, ways to mitigate the impacts of the COVID-19 pandemic on cancer care, and ongoing strategies for preventing and controlling HPV-associated cancers led the conversation at the National Comprehensive Cancer Network® (NCCN®) 2021 Virtual Annual Conference March 18-20.

25 Mar 2021

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

19 Mar 2021

New approach to cancer immunotherapy may prevent autoimmunity

A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at killing cancer cells than current immunotherapy treatments.

19 Mar 2021

Study investigates how genetic variants contribute to increased risk of lung cancer

Lung cancer is the leading cause of cancer death in the U.S. for both men and women. While risk for this disease can be influenced by environmental and lifestyle factors like smoking, studies estimate that 18% of lung cancer cases are due to inherited genetic variants.

18 Mar 2021

UTSW researchers identify the structure of a key cell-surface protein

UT Southwestern researchers have identified the structure of a key member of a family of proteins called nicotinic acetylcholine receptors in three different shapes.

17 Mar 2021

Chromatin-regulating enzyme found to be a key driver of common lung cancer

A chromatin-regulating enzyme has been shown by in-depth interdisciplinary investigations to be a key driver of a common type of lung cancer. Drugs that target the enzyme could improve treatment and survival rates for this particular cancer.

15 Mar 2021

Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer

Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC).

15 Mar 2021

Study opens the door to new possibilities targeting telomeres to help treat cancer

The Telomeres and Telomerase Group led by Maria A. Blasco at the Spanish National Cancer Research Centre continues to make progress in unraveling the role that telomeres -the ends of chromosomes that are responsible for cellular aging as they shorten- play in cancer.

10 Mar 2021

Decision-making between patient and doctor is crucial before lung cancer screening

In a viewpoint perspective published in JAMA on March 9, 2021, a University of North Carolina Lineberger Comprehensive Cancer Center researcher and two other experts endorsed the Center for Medicare & Medicaid Services' (CMS) requirement for a patient and their doctor to engage in a shared discussion of benefits and harms before proceeding with a low-dose spiral computed tomography (LDCT) scan as a method for preventing lung cancer death.

10 Mar 2021

Future lung cancer screening strategies should address equity, implementation issues, say experts

Calling the U.S. Preventive Services Task Force's newly released recommendation statement to expand eligibility for annual lung cancer screening with low-dose computed tomography a step forward, UNC Lineberger Comprehensive Cancer Center researchers say future changes should address equity and implementation issues.

10 Mar 2021

Novel method can improve the detection of circulating tumor cells

Non-Small Cell Lung Cancer (NSCLC) is the most prevalent form of lung cancer, accounting for more than 80 percent of all lung cancer cases.

10 Mar 2021

Lung Cancer News and Research

Latest Lung Cancer News and Research

Study paves way for effective monitoring of chemotherapeutic drug level in cancer patients

Study: More than 60% of adult e-cigarette users in the U.S want to quit

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Researchers receive $4.5 million grant to support lung cancer screenings and research

Objectives, challenges and opportunities of new IASLC Molecular Database Project

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

UVA expert helps develop new lung cancer screening guidelines for high-risk patients

UCLA researchers receive NIH grants to identify new ways to treat pancreatic cancer

Smoking cessation therapy for hospitalized patients may help avoid many premature deaths

NCCN Annual Conference discusses new ways to improve cancer care

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

New approach to cancer immunotherapy may prevent autoimmunity

Study investigates how genetic variants contribute to increased risk of lung cancer

UTSW researchers identify the structure of a key cell-surface protein

Chromatin-regulating enzyme found to be a key driver of common lung cancer

Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer

Study opens the door to new possibilities targeting telomeres to help treat cancer

Decision-making between patient and doctor is crucial before lung cancer screening

Future lung cancer screening strategies should address equity, implementation issues, say experts

Novel method can improve the detection of circulating tumor cells

Breath Analysis: How Could it Improve Healthcare and Diagnosis?

Advancing the Diagnosis and Treatment of Ovarian Cancer

World Health Day 2021 – “Building a fairer, healthier world”

Lung Cancer News and Research

Latest Lung Cancer News and Research

Newsletters you may be interested in